5433-02-3

Usage

Uses

Used in Pharmaceutical Industry:
N-(3-methyl-4-sulfamoylphenyl)acetamide is used as a potential antibacterial agent for its sulfonamide structure, which is known for its antibacterial properties in medicine.
Used in Chemical Research:
N-(3-methyl-4-sulfamoylphenyl)acetamide is used as a research compound for studying the properties and applications of sulfonamide-based compounds in various chemical and biological contexts.

Upstream product

• 62374-67-8 4-acetamino-2-methyl-benzenesulfonyl chloride 
• 537-92-8 3-Methylacetanilide 

Downstream Products

• 6324-76-1 5-benzoylamino-toluene-2-sulfonic acid amide 
• 23202-51-9 5-hydroxy-toluene-2-sulfonic acid amide 
• 857617-21-1 5-acetylamino-4-bromo-toluene-2-sulfonic acid amide 
• 94109-57-6 4-amino-2-methylbenzenesulfonamide 
• 55289-62-8 N-(1,1-dioxide-3-oxo-2,3-dihydrobenzo[d]isothiazol-5-yl)acetamide 

Relevant academic research and scientific papers

1-PHENYLPYRROLE COMPOUNDS

The present invention comprises a compound for the prevention and/or treatment of cardiovascular diseases, nephropathy, fibrosis, primary aldosteronism or edema. The compound is of the following general formula (I): wherein R1 represents a C1 -C3 alkyl group; R2 represents a hydroxy -C1 -C4 alkyl group and the like; R3 represents a halogeno group, a halogeno-C1 -C3 alkyl group and the like; R4 represents a hydrogen atom, a halogeno group and the like,- R5 represents a sulfamoyl group or a C1-C3 alkylsulf onyl group; R6 represents a hydrogen atom, a halogeno group and the like] or an N-oxide, atropisomer of the foregoing, or pharmaceutically acceptable salt of the foregoing.

ANTIPROLIFERATIVE 2-(SULFO-PHENYL)-AMINOTHIAZOLE DERIVATIVES

Aminothiazole compounds substituted with sulfur-containing groups are represented by the Formula (I), and their pharmaceutically acceptable salts, prodrugs, active metabolites, and pharmaceutically acceptable salts of said metabolites are described. These agents modulate and/or inhibit the cell proliferation and activity of protein kinases and are useful as pharmaceuticals for treating malignancies and other disorders.

New processes for the synthesis of 2,6-dichloro-3- methylaniline-Ph-UL-14C and methyl 6-chloroanthranilate-Ph-UL-14C

Two new processes were developed for the synthesis of 2,6-dichloro-3-methylaniline-Ph-UL-14C (1), a key intermediate in the synthesis of a DowElanco experimental product presently being considered for commercialization. Both processes afford product in much higher yields than that previously reported in the literature. One of the processes was subsequenly applied to the synthesis of methyl 6-chloroanthranilate-Ph-14C (12), used as an intermediate for a second potential product.